Anemia due to antineoplastic chemotherapy
ICD-10 D64.81 is a billable code used to indicate a diagnosis of anemia due to antineoplastic chemotherapy.
Anemia due to antineoplastic chemotherapy is a condition characterized by a reduction in red blood cell count, hemoglobin concentration, or hematocrit levels resulting from the cytotoxic effects of chemotherapy agents used in cancer treatment. This type of anemia is often classified as an acquired anemia, specifically linked to the suppression of bone marrow function, which is a common side effect of many chemotherapeutic agents. Patients undergoing chemotherapy may experience aplastic anemia, where the bone marrow fails to produce sufficient blood cells, leading to a significant decrease in red blood cells, white blood cells, and platelets. The pathophysiology involves the direct toxicity of chemotherapy drugs on hematopoietic stem cells, resulting in impaired erythropoiesis. Clinically, patients may present with symptoms such as fatigue, pallor, shortness of breath, and increased susceptibility to infections. Monitoring hemoglobin levels and complete blood counts is essential in managing these patients, and supportive care, including blood transfusions or erythropoiesis-stimulating agents, may be necessary to alleviate symptoms and improve quality of life.
Detailed records of chemotherapy regimens, patient responses, and lab results.
Patients receiving chemotherapy for various cancers presenting with fatigue and pallor.
Close monitoring of blood counts and timely documentation of any transfusions or supportive care provided.
Comprehensive evaluation of blood counts, bone marrow biopsy results, and treatment plans.
Patients with persistent anemia post-chemotherapy requiring further evaluation.
Differentiating between chemotherapy-induced anemia and other hematologic disorders.
Used when a patient with D64.81 requires a blood transfusion due to severe anemia.
Document the indication for transfusion and patient response.
Oncology specialists should note the patient's chemotherapy history.
Documentation must include the patient's chemotherapy treatment history, lab results indicating anemia, and any related clinical findings. It is essential to link the anemia directly to the chemotherapy received.
